Allena Pharmaceuticals, Inc.
ALNAQ · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $19 | $42 | $61 | $113 |
| - Cash | $30 | $35 | $30 | $62 |
| + Debt | $1 | $10 | $10 | $10 |
| Enterprise Value | -$10 | $17 | $41 | $61 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$32 | -$33 | -$47 | -$36 |
| % Margin | – | – | – | – |
| Net Income | -$33 | -$33 | -$47 | -$36 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -1.01 | -2.13 | -1.72 |
| % Growth | -2% | 52.6% | -23.8% | – |
| Operating Cash Flow | -$46 | -$28 | -$44 | -$32 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$46 | -$29 | -$44 | -$32 |